Company Profile

Phaeno Inc
Profile last edited on: 12/5/23      CAGE: 8ZX03      UEI: G7J2G5J68W97

Business Identifier: Precision sequencing for precision medicine
Year Founded
2018
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8 Saint Martins Road
Baltimore, MD 21218
   (410) 241-2207
   N/A
   www.phaenobiotech.com
Location: Single
Congr. District: 07
County: Baltimore City

Public Profile

Created to advance original concepts and technology in pursuit of precision medicine, Phaeno Inc is stucture around transforming biomedical approaches to a range of diseases: Alzheimer’s, Parkinson; Advanced Cancers; AIDS; Lyme and Covid-19. Able to pnpoint the molecules responsible for disease and the drug targets for treatment, the firm's developed proprietary Precision Sequencing technology has solved a longstanding technical limitation with accurate large scale, full length, single molecule sequencing.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $398,040
Project Title: Full-length sequencing of individual RNAs from heterogeneous samples

Key People / Management

  William S Agnew -- Co-Founder, Chief Executive Officer & Co-Inventor

  Mark C Emerick -- Co-Inventor Cofounder

  Bill Haack -- Chief Business Officer

  Hedi Mouchard -- Chief Operating Officer Cofounder

  Giovanni Parmigiani -- Computational Biostatistician Co-founder

Company News

There are no news available.